Canada
· Delayed Price · Currency is CAD Medicenna Therapeutics Statistics
Total Valuation
TSX:MDNA has a market cap or net worth of CAD 82.13 million. The enterprise value is 52.30 million.
| Market Cap | 82.13M |
| Enterprise Value | 52.30M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:MDNA has 78.22 million shares outstanding. The number of shares has increased by 7.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 78.22M |
| Shares Change (YoY) | +7.07% |
| Shares Change (QoQ) | +1.52% |
| Owned by Insiders (%) | 15.28% |
| Owned by Institutions (%) | n/a |
| Float | 50.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.71 |
| P/TBV Ratio | 4.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.94 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.19 |
Financial Position
The company has a current ratio of 10.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.09 |
| Quick Ratio | 9.90 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -149.09% and return on invested capital (ROIC) is -64.43%.
| Return on Equity (ROE) | -149.09% |
| Return on Assets (ROA) | -42.08% |
| Return on Invested Capital (ROIC) | -64.43% |
| Return on Capital Employed (ROCE) | -64.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.68M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.79% in the last 52 weeks. The beta is 1.76, so TSX:MDNA's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | -44.79% |
| 50-Day Moving Average | 1.03 |
| 200-Day Moving Average | 1.68 |
| Relative Strength Index (RSI) | 56.31 |
| Average Volume (20 Days) | 23,931 |
Short Selling Information
The latest short interest is 222,810, so 0.29% of the outstanding shares have been sold short.
| Short Interest | 222,810 |
| Short Previous Month | 150,128 |
| Short % of Shares Out | 0.29% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.69M |
| Pretax Income | -26.90M |
| Net Income | -26.90M |
| EBITDA | -18.67M |
| EBIT | -18.69M |
| Earnings Per Share (EPS) | -0.36 |
Balance Sheet
The company has 30.00 million in cash and 174,000 in debt, giving a net cash position of 29.82 million or 0.38 per share.
| Cash & Cash Equivalents | 30.00M |
| Total Debt | 174,000 |
| Net Cash | 29.82M |
| Net Cash Per Share | 0.38 |
| Equity (Book Value) | 17.45M |
| Book Value Per Share | 0.22 |
| Working Capital | 28.84M |
Cash Flow
In the last 12 months, operating cash flow was -16.34 million and capital expenditures -33,000, giving a free cash flow of -16.37 million.
| Operating Cash Flow | -16.34M |
| Capital Expenditures | -33,000 |
| Free Cash Flow | -16.37M |
| FCF Per Share | -0.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:MDNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.07% |
| Shareholder Yield | -7.07% |
| Earnings Yield | -32.75% |
| FCF Yield | -19.94% |
Stock Splits
The last stock split was on March 3, 2017. It was a reverse split with a ratio of 0.0714285.
| Last Split Date | Mar 3, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.0714285 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |